Rgenomics has decided to conduct a 1-for-1 stock dividend, allotting one new common share for each existing common share held by current shareholders.

The company announced in a regulatory filing that it held a board meeting on the 15th and finalized a plan for a stock dividend issuing 14,027,718 new common shares. The record date for the new share allotment in this stock dividend is June 30, 2026.

The total number of issued shares, currently at 14,027,718, will double to 28,055,436 after the stock dividend, as an identical number of new shares is added. The scheduled listing date for the new shares is July 21, 2026, and the dividend start date has been set to January 1, 2026.

The company will carry out the stock dividend by capitalizing 7,013,859,000 won from the excess paid-in capital. As a result, the number of shares will increase, but no new funds will flow into the company, and no fractional shares will be generated, the company explained.

Meanwhile, the Korea Exchange suspended trading of Rgenomics common shares starting from 4:49 p.m. on the 15th until the end of the trading session, following the stock dividend decision. The Exchange stated that this is a measure taken in accordance with Article 37 of the KOSDAQ Market Disclosure Regulations and Article 18 of the Enforcement Detailed Rules, and added that after-hours trading will not be executed before the market opens on the day trading resumes.